Back
Novartis AG 10K Form
Buy
60
NVSEF
Novartis AG
Last Price:
$106.00
Seasonality Move:
-0.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVSEF News And Ratings
See the #1 stock for the next 7 days that we like better than NVSEF
NVSEF Financial Statistics
Sales & Book Value
Annual Sales: | $51.7B |
---|---|
Cash Flow: | $3.1B |
Price / Cash Flow: | 15.62 |
Annual Sales: | $22.30 |
Price / Book: | 4.75 |
Profitability
EPS (TTM): | 5.88000 |
---|---|
Net Income (TTM): | $11.9B |
Gross Margin: | $38.9B |
Return on Equity: | 27.64% |
Return on Assets: | 12% |
Novartis AG Earnings Forecast
Key Novartis AG Financial Ratios
-
The Gross Profit Margin over the past 27 years for NVSEF is 75.20%.
-
The Selling, General & Administrative Expenses for NVSEF have been equal to 24.30% of Gross Profit Margin.
-
The Research & Development expenses have been 19.38% of Revenue.
-
The Interest Expense is 8.42% of Operating Income.
-
The Net Earning history of NVSEF is 23.09% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 17 years.
Novartis AG Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | NVSEF |
Website: | novartis.com |
Debt
Debt-to-Equity Ratio: | 0.67 |
---|---|
Current Ratio: | 1.04 |
Quick Ratio: | 0.8 |
Price-to-Earnings
Trailing P/E Ratio: | 18.06 |
---|---|
Forward P/E Ratio: | 0 |
NVSEF Technical Analysis vs Fundamental Analysis
Buy
60
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy or a Sell?
-
Novartis AG stock is rated a BuyThe current Novartis AG [NVSEF] share price is $106.00. The Score for NVSEF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.